Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.

Kevin C Soares Joshua S JolissaintSarah M McIntyreKenneth P SeierMithat GönenCarlie SigelNaaz NasarAndrea CercekJames J Harding Nancy E KemenyLouise C ConnellBas Groot KoerkampVinod P BalachandranMichael I D'AngelicaJeffrey A DrebinT Peter KinghamAlice C WeiWilliam R Jarnagin

Published in: Cancer medicine (2023)

In patients with liver-limited IHC, hepatic disease control is associated with improved OS, emphasizing the potential importance of liver-directed therapy.

Keyphrases

stem cells
risk assessment
climate change
mesenchymal stem cells
cell therapy
human health